DNA Stock-Based Compensation
$62.32MTTM · USD
Period ending:
DNA FY Stock-Based CompUSD
$1.93B$0.00
2019-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
DNA stock-based compensation history
Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 81,546,000 | |
| 112,344,000 | |
| 229,884,000 | |
| 1,930,641,000 | |
| 1,606,020,000 | |
| 476,000 | |
| 771,000 |
Compare stock-based compensation
All DNA financial metrics · DNA stock overview · How to interpret financial metrics
